GlassScriptPhysician profile
April Whitfield
NPI 1083640221
$3,362.63
in general payments reported to CMS, 2019-2025
34 companies · $726 in 2025
The $726 reported for 2025 was more than what 84% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $478 · 2020: $271 · 2021: $508 · 2022: $528 · 2023: $604 · 2024: $249 · 2025: $726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,578.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $630.07 | 2019-2024 | Orilissa, Lo Loestrin Fe, Ubrelvy |
| Bayer Healthcare Pharmaceuticals INC. | $312.42 | 2019-2025 | |
| Astellas Pharma US INC | $280.54 | 2022-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $230.22 | 2021-2023 | |
| Channel Medsystems, INC. | $193.99 | 2022-2023 | |
| Organon LLC | $190.20 | 2021-2025 | Nexplanon, Jada System |
| Sage Therapeutics, LLC | $185.07 | 2024-2025 | Zurzuvae |
| Daiichi Sankyo INC. | $182.73 | 2019-2022 | |
| Stryker Corporation | $134.43 | 2022-2025 | 1788 |
| Boston Scientific Corporation | $87.86 | 2022-2025 | Bulkamid - Bulkamid Urethral Bulking Pack 2ml (Ous) |
| Hologic Sales and Service, LLC | $86.45 | 2021-2024 | Coolseal Generator, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Coopersurgical, INC. | $78.73 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Roche Diagnostics Corporation | $76.63 | 2019-2020 | |
| Myriad Women'S Health, INC. | $76.63 | 2023 | Myrisk |
| Millicent US INC | $59.39 | 2023-2025 | Intrarosa, Femring, Femlyv |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $55.40 | 2019-2021 | |
| Avion Pharmaceuticals | $51.10 | 2021-2022 | |
| Therapeuticsmd, INC. | $49.19 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $48.04 | 2025 | Qelbree |
| Vertex Pharmaceuticals Incorporated | $47.54 | 2024-2025 | |
| Exeltis, USA INC. | $43.19 | 2025 | Slynd |
| Allergan, INC. | $38.08 | 2019 | |
| Sumitomo Pharma America, INC. | $28.79 | 2023-2025 | Myfembree |
| Pacira Pharmaceuticals Incorporated | $28.53 | 2023 | Exparel |
| Mylan Pharmaceuticals INC. | $25.29 | 2020-2022 | |
| Lupin INC. | $21.85 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.02 | 2020 | |
| Avanos Medical | $16.98 | 2019 | |
| Conmed Corporation | $16.71 | 2025 | Airseal, Vcare |
| Ascend Therapeutics US, LLC | $14.81 | 2021 | |
| Ethicon US, LLC | $14.72 | 2019 | |
| Urovant Sciences INC | $13.16 | 2022 | |
| Aspira Women'S Health INC | $12.95 | 2020 | |
| Evofem Biosciences, INC. | $11.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Whitfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.